April 23, 2024 Clinical Outcome Assessment — Initial Public Discussion In this presentation from C-Path's rare and orphan disease program, you will see...
April 22, 2024 Unlocking the Capabilities of Large Language Models for Accelerating Drug Development Recent breakthroughs in natural language processing (NLP), particularly in large language models (LLMs), offer substantial...
April 17, 2024-April 18, 2024 2024 Clinical Outcome Assessment Program Annual Meeting On April 17-18, 2024, the 2024 Clinical Outcome Assessment Annual Meeting...
April 10, 2024 Critical Path Institute Announces New Board Members Bonnie A. Allin and Louis Breton Critical Path Institute (C-Path) today announced the appointments of Bonnie A. Allin and Louis Breton to its Board of Directors.
April 1, 2024 C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development
March 28, 2024 C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of...
March 26, 2024 C-Path Launches Consortium for Alpha-1 Antitrypsin Deficiency Critical Path Institute (C-Path) is excited to announce the launch of the Critical Path for Alpha-1 Antitrypsin Deficiency...
March 25, 2024 C-Path to Spearhead New Task Force Dedicated to Accelerating Drug Development for Progressive Supranuclear Palsy Critical Path Institute (C-Path) today announced the formation of a new task force...
March 15, 2024 C-Path’s CURE Drug Repurposing Collaboratory Aims to Document 1,000 Cases on the CURE ID App for Long COVID Awareness Day TUCSON, Ariz., March 15, 2024 — Critical Path Institute’s (C-Path) CURE Drug Repurposing Collaboratory (CDRC), a leading advoc
